Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales: Niswander, Lisa M., Loftus, Joseph P, Lainey, Élodie, Caye-Eude, Aurélie, Pondrom, Morgane, Hottman, David A., Iacobucci, Ilaria, Mullighan, Charles G., Jain, Nitin, Konopleva, Marina, Cavé, Hélène, Baruchel, André, Rohrlich, Pierre S., Tasian, Sarah K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485673/
https://www.ncbi.nlm.nih.gov/pubmed/34196168
http://dx.doi.org/10.3324/haematol.2021.278697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485673/
https://www.ncbi.nlm.nih.gov/pubmed/34196168
http://dx.doi.org/10.3324/haematol.2021.278697

Ejemplares similares